Community/Retail

This marks the first FDA-approved treatment for this rare lipid storage disease.

In children aged 1 to 3 years, the VP250 peanut patch was superior to placebo in the desensitization to peanuts and increasing the peanut dose that triggers allergic symptoms.

Treatment with semaglutide yielded superior effects on drinking outcomes compared with existing therapies to reduce alcohol cravings.

Semaglutide has been approved for reducing kidney disease progression and cardiovascular risk in patients with type 2 diabetes, marking a significant advancement in CKD management.

PfSPZ-LARC2 is a genetically engineered malaria vaccine that marks a significant step forward in combating malaria around the world.

Educating patients about lifestyle modifications is a critical part of preventing cerebrovascular events.

Embedding a pharmacist in the dermatology clinic improved clinical and financial outcomes.

QPL use in the pharmacy setting may enhance patient engagement while allowing pharmacists to showcase their medication-related expertise.

Many patients may struggle to understand the complex immunization schedules compiled by the CDC.

Research suggests H5N1 may be spreading undetected among humans, particularly in veterinarians with frequent animal exposure.

All stakeholders should work together to determine and address drug shortages.

Phil Vigeant shares insights on the health benefits of protein supplements and guidance for consumers to identify safe and effective protein powder products.

New data from the longest known trial of pediatrics and adolescents in the postacute phase of COVID-19 show they are at a heightened risk of gastrointestinal tract symptoms.

Clinical decision support systems based on algorithms have improved outcomes and reduced costs in other health care settings.

Donna Ryan explains why long-term treatment with GLP-1 medication is typically necessary to maintain weight loss benefits.

The approval makes the vaccine the first of its kind for this indication in the United States.

The authors are optimistic that these findings may help develop defenses to prevent food allergies in at-risk infants.

Future research can explore the underlying cause of recurrent pericarditis with systemic Sjögren syndrome and the combination of rilonacept with immunosuppressive therapies.

The authors suggest future research should consider inflammation and the gut as potential therapeutic targets improve depression in patients with chronic kidney disease (CKD).

Pharmacists should emphasize the importance of medication adherence and lifestyle changes.

Invasive meningococcal disease is a severe bacterial infection caused by the bacterium Neisseria meningitidis, often leading to meningitis or sepsis.

RSV poses a significant threat to high-risk adults, but effective vaccines offer strong protection, highlighting the need for increased vaccination rates and education.

Insulin-aspart-szjj (Merilog) is the first rapid-acting insulin biosimilar product approved by the FDA.

PP-01 could become a first-in-class treatment for patients with cannabis use disorder.

Therapies like the newly approved suzetrigine, a nonopioid NaV1.8 pain signal inhibitor, could revolutionize pain management and mitigate the risks associated with opioid use.

Treatment with 2.4 mg of semaglutide did not increase the risk of developing suicidal ideation or behavior compared with placebo.